Capitalizing a Cure. How Finance Controls the Price and Value of Medicines

Capitalizing a Cure. How Finance Controls the Price and Value of Medicines.
Roy, Victor (2023). Oakland, California. University of California Press. (Book; English).

Full Text Available As:
[thumbnail of 2023_roy_capitalizing_a_cure_front.jpg]
Preview
Cover Image
2023_roy_capitalizing_a_cure_front.jpg

Download (132kB) | Preview
[thumbnail of Full Text]
Preview
PDF (Full Text)
2023_roy_capitalizing_a_cure.pdf

Download (3MB) | Preview
[thumbnail of Full Text -- EPUB] Other (Full Text -- EPUB)
2023_roy_capitalizing_a_cure.epub

Download (3MB)
[thumbnail of Full Text -- MOBI] Other (Full Text -- MOBI)
2023_roy_capitalizing_a_cure.mobi

Download (8MB)

Alternative Locations

https://luminosoa.org/site/books/m/10.1525/luminos.141/, https://www.econstor.eu/handle/10419/268413

Abstract or Brief Description

Capitalizing a Cure takes readers into the struggle over a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When curative treatments for hepatitis C launched in 2013, sticker shock over their prices intensified the global debate over access to new medicines. Weaving historical research with insights from political economy and science and technology studies, Victor Roy demystifies an oft-missed dynamic in this debate: the reach of financialized capitalism into how medicines are made, priced, and valued.

Roy’s account moves between public and private labs, Wall Street and corporate board rooms, and public health meetings and health centers to trace the ways in which curative medicines became financial assets dominated by strategies of speculation and extraction at the expense of access and care. Provocative and sobering, this book illuminates the harmful impact of allowing financial markets to determine who heals and who suffers and points to the necessary work of building more equitable futures.

Language

English

Publication Type

Book

Keywords

capitalization capital as power finance Gilead Sciences health pharmaceutical price profit R&D sabotage Veblen

Subject

BN Law
BN Money & Finance
BN Power
BN Policy
BN Production
BN Region - North America
BN Science & Technology
BN Agency
BN State & Government
BN Value & Price
BN Business Enterprise
BN Capital & Accumulation
BN Distribution
BN Industrial Organization
BN Institutions

Depositing User

Jonathan Nitzan

Date Deposited

28 Jan 2023 02:37

Last Modified

01 Feb 2023 18:33

URL:

https://bnarchives.net/id/eprint/763

Actions (login required)

View Item View Item